Valuation: AbbVie Inc.

Market Cap 442B 383B 359B 327B 616B 42,152B 626B 4,204B 1,647B 21,098B 1,659B 1,623B 70,387B P/E 2026 *
31.9x
P/E 2027 * 23.6x
Enterprise Value 502B 435B 407B 372B 700B 47,906B 711B 4,778B 1,872B 23,978B 1,886B 1,845B 79,995B EV / Sales 2026 *
7.43x
EV / Sales 2027 * 6.71x
Free-Float
95.71%
Yield 2026 *
2.74%
Yield 2027 * 2.88%
1 day-0.83%
1 week+0.41%
Current month-1.48%
1 month-0.31%
3 months+18.94%
6 months+8.67%
Current year+8.20%
1 week 241.2
Extreme 241.2
250.76
1 month 241.2
Extreme 241.2
267.47
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

62 0.0000%
30/06/26 Free

Director

134 0.0000%
08/05/26 Free

Director

1,118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+0.41%+24.46%+62.36% 442B
-0.69%+2.58%+87.67%+123.05% 1,083B
-0.62%-0.46%+48.41%+47.84% 626B
-1.61%-0.74%+46.92%+36.68% 363B
-1.49%-0.82%+28.28%+35.77% 295B
-1.10%-2.99%+5.32%+5.06% 248B
-0.24%+0.73%+44.16%+57.42% 224B
-2.87%+1.07%-7.19%-51.97% 210B
-0.14%+1.62%+11.56%+67.68% 168B
-0.88%+2.09%+6.90%-26.95% 152B
Average -1.07%+3.40%+29.65%+35.69% 381.08B
Weighted average by Cap. -0.96%+4.44%+45.69%+59.08%

Financials

2026 *2027 *
Net sales 67.58B 58.57B 54.83B 50.03B 94.14B 6,446B 95.73B 643B 252B 3,226B 254B 248B 10,764B 73.51B 63.7B 59.64B 54.42B 102B 7,011B 104B 699B 274B 3,509B 276B 270B 11,708B
Net income 13.86B 12.01B 11.25B 10.26B 19.31B 1,322B 19.63B 132B 51.66B 662B 52.05B 50.91B 2,208B 18.9B 16.38B 15.33B 13.99B 26.33B 1,803B 26.77B 180B 70.45B 902B 70.97B 69.42B 3,010B
Net Debt 60.33B 52.28B 48.94B 44.66B 84.04B 5,754B 85.45B 574B 225B 2,880B 227B 222B 9,609B 51.47B 44.6B 41.75B 38.1B 71.69B 4,909B 72.9B 490B 192B 2,457B 193B 189B 8,197B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
12/08/26 $247.72 -0.95% 132,469
11/08/26 $250.09 +0.85% 4,485,470
10/08/26 $247.97 +0.78% 4,209,941
07/08/26 $246.04 +0.89% 4,930,711
06/08/26 $243.87 -0.95% 4,570,167
Trader
Investor
Global
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
250.09USD
Average target price
275.39USD
Spread / Average Target
+10.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock